文献速递腹部MR

胰腺癌的磁共振成像早期特征:一项病例对照研究

Early features of pancreatic cancer on magnetic resonance imaging (MRI): a case-control study.
PubMed 文献 · Abdom Radiol (NY) · 2024-04-05

在Kaiser Permanente南加州机构2008至2018年开展的病例对照研究中,141例胰腺癌患者诊断前2-36个月的MRI与292例匹配对照相比,更多出现主胰管扩张、局灶性胰管狭窄伴远端扩张、胰管不规则、分支胰管局灶性扩张及胰腺实质萎缩、局灶性信号异常,这些导管和实质特征与胰腺癌风险升高相关。

要点

  • 诊断前MRI上主胰管扩张、局灶性狭窄伴远端扩张、胰管不规则及分支胰管局灶性扩张均与胰腺癌风险升高相关。
  • 胰腺实质萎缩和局灶性信号异常在胰腺癌病例诊断前MRI上更常见。
  • 仅17%的病例在诊断前MRI上可见实性肿块,多数早期征象为导管或实质异常。

核心结论

  • 除可能漏诊的病灶外,MRI上的一系列导管和实质特征与发生胰腺癌的 odds 升高相关。

研究设计与样本

  • 病例对照研究,纳入141例胰腺癌病例和292例按年龄、性别、种族/族裔、对比剂使用状态和扫描年份1:2匹配的对照,病例均有诊断前2-36个月的MRI检查,排除急/慢性胰腺炎或既往胰腺手术史者,由盲法阅片评估预设的实质和导管特征。

关键影像表现/征象

  • 病例组诊断前MRI上实性肿块仅见于24例(17%)。
  • 病例组主胰管扩张出现率为51.4%,对照组为14.3%。
  • 病例组局灶性胰管狭窄伴远端(上游)扩张出现率为43.6%,对照组为5.6%。
  • 病例组胰管不规则出现率为42.1%,对照组为6.0%。
  • 病例组分支胰管局灶性扩张出现率为13.6%,对照组为1.6%。

诊断标准与关键数值

  • 主胰管扩张与胰腺癌的OR为7.75(95%CI 4.19-15.44),P<0.001。
  • 局灶性胰管狭窄伴远端扩张与胰腺癌的OR为12.71(95%CI 6.02-30.89),P<0.001。
  • 胰管不规则与胰腺癌的OR为9.73(95%CI 4.91-21.43),P<0.001。
  • 分支胰管局灶性扩张与胰腺癌的OR为11.57(95%CI 3.38-61.32),P<0.001。

临床应用与阅片要点

  • 阅片时除寻找实性肿块外,应关注主胰管扩张、局灶性狭窄伴远端扩张、胰管不规则和分支胰管局灶性扩张等导管征象。
  • 胰腺实质萎缩和局灶性信号异常可作为提示胰腺癌风险升高的实质特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Magnetic resonance imaging has been recommended as a primary imaging modality among high-risk individuals undergoing screening for pancreatic cancer. We aimed to delineate potential precursor lesions for pancreatic cancer on MR imaging.

METHODS: We conducted a case-control study at Kaiser Permanente Southern California (2008-2018) among patients that developed pancreatic cancer who had pre-diagnostic MRI examinations obtained 2-36 months prior to cancer diagnosis (cases) matched 1:2 by age, gender, race/ethnicity, contrast status and year of scan (controls). Patients with history of acute/chronic pancreatitis or prior pancreatic surgery were excluded. Images underwent blind review with assessment of a priori defined series of parenchymal and ductal features. We performed logistic regression to assess the associations between individual factors and pancreatic cancer. We further assessed the interaction among features as well as performed a sensitivity analysis stratifying based on specific time-windows (2-3 months, 4-12 months, 13-36 months prior to cancer diagnosis).

RESULTS: We identified 141 cases (37.9% stage I-II, 2.1% III, 31.4% IV, 28.6% unknown) and 292 matched controls. A solid mass was noted in 24 (17%) of the pre-diagnostic MRI scans. Compared to controls, pre-diagnostic images from cancer cases more frequently exhibited the following ductal findings: main duct dilatation (51.4% vs 14.3%, OR [95% CI]: 7.75 [4.19-15.44], focal pancreatic duct stricture with distal (upstream) dilatation (43.6% vs 5.6%, OR 12.71 [6.02-30.89], irregularity (42.1% vs 6.0%, OR 9.73 [4.91-21.43]), focal pancreatic side branch dilation (13.6% vs1.6%, OR 11.57 [3.38-61.32]) as well as parenchymal features: atrophy (57.9% vs 27.4%, OR 46.4 [2.71-8.28], focal area of signal abnormality (39.3% vs 4.8%, OR 15.69 [6.72-44,78]), all p < 0.001).

CONCLUSION: In addition to potential missed lesions, we have identified a series of ductal and parenchymal features on MRI that are associated with increased odds of developing pancreatic cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Parker RA, Zhou Y, Puttock EJ, et al. Early features of pancreatic cancer on magnetic resonance imaging (MRI): a case-control study. Abdom Radiol (NY). 2024. PMID: 38580790. doi:10.1007/s00261-024-04271-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。